Rescue Medicine Switch Concept Draws Criticism
This article was originally published in The Tan Sheet
Executive Summary
FDA considers switching some prescription “antidotes” to restricted nonprescription status so consumers who can self-identify their need for the drugs and who previously had a prescription can easily access them during life-threatening events, says CDER Director Janet Woodcock.